Interstitial Lung Disease in People With Systemic Autoimmune Rheumatic Disease
Key Points
Key Points
Guideline Summary:
- This guideline provides evidence-based recommendations for the screening and treatment of Interstitial Lung Disease (ILD) in people with Systemic Autoimmune Rheumatic Diseases (SARDs) (Rheumatoid Arthritis [RA], Systemic Sclerosis [SSc], Idiopathic Inflammatory Myositis [IIM including polymyositis, dermatomyositis, antisynthetase syndrome, immune-mediated necrotizing myopathy], Mixed Connective Tissue Disease [MCTD], and Sjögren’s Disease [SjD]) associated with the greatest risk of ILD, and for monitoring for ILD progression.
Screening and Monitoring
...ning and Monitorin...
Table 2. Risk Factors for the Developmen...
...mary of Recommendations for Screening of SARD-ILD...
...mendations...
...th SARDsa at increased risk of developing IL...
...th SARDs at increased risk of develo...
...people with SARDs at increased risk of de...
...e with SARDs at increased risk of developing I...
...eople with SARDs at increased risk of...
...with SARDs at increased risk of develop...
...ple with SARDs at increased risk of dev...
...SARDs at increased risk of developing...
...4. Summary of Recommendations for Monitoring fo...
...mendations
...th SARDs-ILD, we conditionally recomme...
...e with SARDs-ILD, we conditionally recommend mo...
...people with SARDs-ILD, we conditionally recomme...
...with SARDs-ILD, we conditionally recommen...
...th SARDs-ILD, we conditionally recommend against...
...r people with SARDs-ILD, we conditionally recom...
...people with SARDs-ILD, we conditional...
...e with IIM-ILD and SSc-ILD, we suggest PFTs...
...with RA-ILD, SjD-ILD, and MCTD-ILD, we sugges...
...SARDs-ILD, we do not provide guidance about freq...
...SARDs-ILD, we suggest assessment for...
...ure 1. Recommendations for ILD Scre...
...igure 2. Interstitial Lung Disease Screening...
Treatment
Treatmen...
...ummary of Recommendations for Managemen...
Recommendation...
...e with SARD-ILD other than SSc-ILD, we condition...
...le with SSc-ILD, we strongly recom...
...r people with SARD-ILD, we conditionally...
...le with SSc-ILD and MCTD-ILD, we conditio...
For people with SARD-ILD, we conditionally reco...
...ith SSc-ILD, we conditionally recommend nin...
...or people with SjD-ILD, IIM-ILD, and MCTD-ILD, we...
...ith RA-ILD, the Panel was not able to come...
...with SARD-ILD, we conditionally recommend...
...ith SARD-ILD receiving mycophenolate without...
For people with SARD-ILD, we conditionall...
...eople with IIM-ILD, we conditionally recommen...
...people with SARD-ILD other than IIM-ILD, we condi...
...th IIM-ILD, we conditionally recommend calcineu...
...h SARD-ILD other than IIM-ILD, we condi...
...people with SARD-ILD, we conditionally recommend...
For people with SARD-associated ILD,...
...ndations for Management of SARD-ILD Progressi...
...ecommendation...
...e strongly recommend against using long-term...
...-ILD we conditionally recommend against using...
...eople with SARD-ILD progression desp...
...ple with RA-ILD progression despite first ILD t...
...eople with SARD-ILD, other than RA-ILD, pro...
For people with SSc-ILD, MCTD-ILD, RA...
For people with SjD-ILD and IIM-ILD progressio...
...with IIM-ILD progression despite first IL...
...le with SARD-ILD, other than IIM-ILD, p...
...people with IIM-ILD progression despite firs...
...IIM-ILD and MCTD-ILD progression despite firs...
...eople with SARD-ILD progression despite first IL...
...eople with SSc-ILD progression despite...
...3. Initital Treatment Options for the Tr...
...Recommendations for Management of SARD-ILD Progre...
...Recommendations for Management of SARD With...
...ecommendations
...eople with SARD and RP-ILD, we con...
...th SARD and RP-ILD, we conditional...
...ople with SARD and RP-ILD, we conditionally...
...eople with RP-ILD, we conditionally recom...
...h SARD and RP-ILD, we conditionally recommen...
...SARD and RP-ILD, we conditionally recommend e...
...ecommendations for Management of SARD...